André C. Kalil

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Remdesivir for the Treatment of Covid-19 — Final Report”.

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine(2020)10.1056/nejmoa2007764

N/A

12.3DataRank · unranked

7738 citations

Kay M Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, André C. Kalil +35 more

Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure

Clinical Infectious Diseases(2020)10.1093/cid/ciaa059

N/A

8.2DataRank · unranked

203 citations

Kathleen Chiotos, Sara E. Cosgrove, Emily L. Heil, Sameer S. Kadri, André C. Kalil +8 more

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals

Arthritis & Rheumatology(2021)10.1002/art.41800

N/A

5.6DataRank · unranked

127 citations

Punyasha Roul, Yangyuna Yang, André C. Kalil, Kaleb Michaud, Geoffrey M. Thiele +4 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102472

N/A

0DataRank · unranked

8 citations

André C. Kalil, Drifa Belhadi, Viviane Cordeiro Veiga, Alexandre Biasi Cavalcanti, Westyn Branch‐Elliman +75 more

Predicting Sepsis Mortality and Costs Using Medicare Claims: A Method to the Madness*

Critical Care Medicine(2020)10.1097/ccm.0000000000004227

N/A

0DataRank · unranked

2 citations

André C. Kalil, Sameer S. Kadri, Lindsay M. Busch

Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper

Clinical Infectious Diseases(2023)10.1093/cid/ciad447

N/A

0DataRank · unranked

33 citations

Jeffrey R. Strich, Kathleen Chiotos, David C. Classen, Sara E. Cosgrove, Ron Greeno +12 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

Choosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence

Clinical Microbiology and Infection(2024)10.1016/j.cmi.2023.12.028

N/A

0DataRank · unranked

19 citations

Suzana M. Lobo, Pedro Póvoa, André C. Kalil, Daniel A. Sweeney

Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae202

N/A

0DataRank · unranked

18 citations

Aastha Chandak, Chidinma Chima-Melton, André C. Kalil, Heng Jiang, Eunyoung Lee +6 more